Targeted Oncology Staff

Based on 3 clinical trials, suggest that when managing toxicities in patients with non-metastatic castration-resistant prostate cancer, oncologists should look at the delta instead of the absolute numbers.

During a Targeted OncologyTM Case-Based Roundtable event, Dan J. Raz, MD, MAS, and peers discussed the challenges of testing in lung cancer and treatment.

An otherwise healthy 60-year-old woman, who has quit smoking for 8 years after 13 pack years, presented with a nonproductive cough. The patient was diagnosed with non–small cell lung cancer. Oncologists discuss the scenario during a Case-Based Roundtable event.

A 59-year-old White male presented with chest pain, cough, and dyspnea and an image-guided biopsy revealed poorly differentiated adenocarcinoma of the lung.

In a 75-year-old patient with metastatic castration-resistant prostate cancer, a bone scan taken at 14-month follow-up showed evidence of 2 lesions in the right hip/pelvis, and abdominal/pelvic CT showed a 2.1-cm left pelvic lymphadenopathy.

Meredith McKean, MD, MPH, moderated a Case-Based Roundtable discussion about a 88-year-old patient with Basel cell carcinoma.

Tanios S. Bekaii-Saab, MD, professor, discussed the factors that may influence treatment for a 50-year-old patient with KRAS/BRAF wild-type colorectal cancer as well as the treatment options available.

Eric Nadler, MD, MPP, led a Case-Based Roundtable discussion on treating a 58-year-old man with thyroid cancer.

Six months after being diagnosed with stage T2N0MO prostate cancer, a 75-year-old patient showed a 2.1-cm left pelvic lymphadenopathy on an abdominal/pelvic CT.

In treating patients with bladder cancer, criteria for treatment differ across practices. Ten oncologists from community practices and academia discussed how they would approach treatment of a 66-year old man with advanced bladder cancer.

A diagnosis of stage IV renal cell carcinoma in a 59-year-old- African American patient was the topic of a discussion led by Christopher W. Ryan, MD.

Jared Weiss, MD, led a discussion about a 59-year-old patient with RET-fusion-positive non–small cell lung cancer during a Targeted Oncology Case-Based Roundtable event.

During a Targeted Oncology Cased-Based Roundtable event, Chandler Park, MD, t discussed the case of a 75-year-old patient with metastatic castration-resistant prostate cancer.

During a Targeted Oncology Case-Based Roundtable event, Miguel Albino, MD, of Texas Oncology, discussed the case of a 73-year-old patient with EGFR-mutant non–small cell lung cancer.

Twelve months after a male patient with RET-mutant thyroid cancer was no longer asymptomatic, the patient developed symptoms that led the treating physician to discover metastatic disease.

Cora N. Sternberg, MD, discusses the case of a 66-year-old woman with bladder cancer.

Grzegorz S. Nowakowski, MD and Stephen D. Smith lead other participants of a Case Based Roundtable event in a discussion around treatment for patients with transplant-ineligible diffuse large B-cell lymphoma.

Karl D. Lewis, MD, the professor of Medicine in the Cutaneous Oncology Program at University of Colorado in Aurora, CO, discussed the case of a 88-year-old patient with Basel cell carcinoma.

During a Targeted Oncology Case-Based Roundtable event, Nelson Jen An Chao, MD of Duke University School of Medicine discussed a 48-year-old patient with graft-vesus-host disease.

Molecular testing revealed RET-mutant non–small cell lung cancer in a 59-year-old patient. The case was a topic of discussion during a Case-Based Roundtable event led by Kartik Konduri, MD.

One year after being diagnosed with CD-10- positive and CD10-positive diffuse large B-cell lymphoma being treated with R-CHOP, and achieving complete remission, a PET/CT scan confirmed relapse in a 74-year-old male patient.

A 59-year-old Black woman received a diagnosis of clear cell renal cell carcinoma. Chung-Han Lee, Md, PhD and a group of other physicians discussed the patient's case during a Case-Based Roundtable event.

Sandy Srinivas, MD of Stanford Health Care, discussed the treatment of a 57-year-old Black man with nonmetastatic castration-resistant prostate cancer over the course of 4 years.

At a live virtual event, David H. Vesole, MD, PhD, explained to other clinicians the use of daratumumab in the treatment of patients with newly diagnosed multiple myeloma who are either eligible or ineligible for autologous stem cell transplant.

John N. Allan, MD, discussed using acalabrutinib for the treatment of a 61-year-old woman with chronic lymphocytic leukemia.

During a Targeted Oncology Case-Based Roundtable event, Noa Biran, MD, discussed the case of a 51-year-old man with newly-diagnosed multiple myeloma.

Haris Ali, MD, discussed the diagnosis and treatment of myelofibrosis with a group of physicians during a Targeted OncologyTCase-Based Roundtable event.

During a Targeted Oncology Case-Based Roundtable event, Natalie S. Callander, MD, discussed the case of a 78-year-old patients with multiple myeloma.

During a Targeted Oncology Case-Based Roundtable event, Nelson Jen An Chao, MD, a discussed the case of a young patient with acute graft-versus-host disease.

Molecular testing practices and treatment decisions can vary for patients with non–small cell lung cancer. Cesar A. Perez, MD, and a group of other physicians discussed next steps in care for a patient with non–small cell lung cancer whose molecular test results revealed a RET mutation.